NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

NWBO is one of many pre revenue biotechs that have the distinction of being identified to short. I really can't say if AdamF finds such companies, and the shorts follow him, or he's an agent who's contacted by those looking to bring down companies, and he just works to bring companies down because that's what he's being paid to do.

Fortunately, in our case, LP has found a way through the minefield set in place by the shorts, the coordinated spoofing by the MM's, etc. and kept the company alive to the point that approvals are on the horizon. While I believe it's a short term horizon for the UK, and we'll see substantial growth in the stock price, but the long term gains are what we should all be holding on for and they'll come with the EDEN being approved for commercial production and then approvals from the other regulators, and acceptance in companies around the world based on the acceptance of the key regulators we'll submit to.

Everything changes when a biotech goes from pre revenue to post revenue and it happens in just an instant. While UK approval doesn't instantly bring in funds, it instantly tells the world that revenue is coming. If we're lucky, we'll get some major media attention when DCVax-L is approved, but without it the company will still have a market cap exceeding a billion, and it should take us above $1. I believe that many here are like me, a little over $1 share price makes this investment a double. Complain all you wish, but few I know would argue with a double in 5 years, 10 years, or even 15 years. This won't stop at just over a double, I suspect for many it could be a ten banger by later this year, almost certainly next. Does it have hundred banger potential and more, almost certainly if it's not bought out, and we give it enough time.

Gary